Article Text

Genetic analysis to predict prognosis at the onset of Crohn’s disease: not yet ready for prime time?
  1. Severine Vermeire,
  2. Gert Van Assche,
  3. Paul Rutgeerts
  1. Department of Gastroenterology, University Hospital, Leuven, Belgium
  1. Dr Severine Vermeire, Department of Gastroenterology, University Hospital, 3000 Leuven, Belgium; Severine.Vermeire{at}

Statistics from

In this issue of Gut, Weersma et al (see page 388) report the results of their study on molecular prediction of disease risk and severity in a large Crohn’s disease cohort.1 This study, performed by the Dutch initiative on Crohn’s disease and colitis (ICC), assessed the risk for disease development and severity by combining information from five Crohn’s disease susceptibility genes. A total of 1684 patients with Crohn’s disease from seven university hospitals were included. The odds ratio for Crohn’s disease susceptibility progressively increased with increasing number of risk alleles and genotypes, a finding that is not unexpected and has also been shown for other common diseases, such as type 2 diabetes, breast cancer and atherosclerosis.2 3 Second, and probably more interesting, was the finding that patients with a more severe disease, patients needing surgery or patients in whom the age at onset of disease was below 40 years carried, on average, more risk alleles compared to patients not meeting these characteristics.

With the identification of several susceptibility genes through genome-wide association scanning, the research on molecular markers in common disorders has gained more attention and comes at a time where the introduction of biological therapies has opened the debate on which therapy to choose for a given patient.

There are several clinical situations where molecular markers are proposed, a first being prediction of disease. Identifying individuals at risk and hence preventing disease is an important strategy for reducing the overall burden of common complex disorders. However, most of the reported genes and risk alleles have a very low …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Inflammatory bowel disease
    R K Weersma P C F Stokkers A A van Bodegraven R A van Hogezand H W Verspaget D J de Jong C J van der Woude B Oldenburg R K Linskens E A M Festen G van der Steege D W Hommes J B A Crusius C Wijmenga I M Nolte G Dijkstra The Dutch Initiative on Crohn and Colitis (ICC)